What do analysts expect the price target to be for CHUBB LTD (CB)?
34 analysts have analysed CB and the average price target is 342.89 USD. This implies a price increase of 4.52% is expected in the next year compared to the current price of 328.06.
NYSE:CB • CH0044328745
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CHUBB LTD (CB).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-10 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2026-02-09 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2026-02-09 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2026-02-09 | Citigroup | Maintains | Buy -> Buy |
| 2026-02-06 | Mizuho | Maintains | Neutral -> Neutral |
| 2026-02-05 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-04 | Citizens | Reiterate | Market Outperform -> Market Outperform |
| 2026-02-04 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-02-04 | Roth Capital | Maintains | Buy -> Buy |
| 2026-02-04 | JP Morgan | Maintains | Neutral -> Neutral |
| 2026-01-16 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2026-01-14 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2026-01-13 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-08 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-08 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2026-01-06 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-12-16 | Mizuho | Initiate | Neutral |
| 2025-11-17 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-27 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-23 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-10-23 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-22 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-10-09 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-08 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-08 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 49.735B 15.40% | 55.753B 12.10% | 59.402B 6.54% | 52.825B -11.07% | 55.631B 5.31% | 74.887B 34.61% | N/A | |
| EBITDA YoY % growth | 9.778B 31.14% | 11.633B 18.97% | 12.981B 11.59% | 13.234B 1.95% | N/A | N/A | N/A | |
| EBIT YoY % growth | 9.468B 32.03% | 11.31B 19.46% | 12.68B 12.11% | 13.071B 3.08% | 13.759B 5.26% | 14.138B 2.75% | 12.025B -14.95% | |
| Operating Margin | 19.04% | 20.29% | 21.35% | 24.74% | 24.73% | 18.88% | N/A | |
| EPS YoY % growth | 19.82 30.05% | 22.53 13.67% | 24.83 10.21% | 27.58 11.07% | 29.90 8.43% | 33.09 10.66% | 26.68 -19.39% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 6.77 83.84% | 6.89 12.27% | 6.24 -16.68% | 7.32 -2.65% | 7.36 8.74% | 7.44 7.90% | 6.95 11.35% | 7.99 9.12% | 8.52 15.79% | 8.55 14.93% | 7.41 6.62% |
| Revenue Q2Q % growth | 12.067B 10.44% | 13.369B 7.87% | 14.012B 8.33% | 11.999B 6.10% | 12.47B 3.34% | 14.152B 5.86% | 14.726B 5.10% | 12.783B 6.53% | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 3.213B 80.51% | 3.228B -17.46% | 2.877B -29.17% | 2.722B -24.01% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
34 analysts have analysed CB and the average price target is 342.89 USD. This implies a price increase of 4.52% is expected in the next year compared to the current price of 328.06.
CHUBB LTD (CB) will report earnings on 2026-04-20, after the market close.
The consensus EPS estimate for the next earnings of CHUBB LTD (CB) is 6.77 USD and the consensus revenue estimate is 12.07B USD.
The consensus rating for CHUBB LTD (CB) is 72.9412 / 100 . This indicates that analysts generally have a positive outlook on the stock.